Nymox Pharmaceutical Corp (NYMX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -946.84 | -884.651 | -233.992 | -194.058 | -238.771 | -433.356 | -428.683 | -785.435 |
Return on Equity (%) | 772.481 | 1419.556 | -368.423 | -251.904 | -419.739 | -1529.835 | 1331.174 | 483.94 |
Return on Invested Capital (%) | 1529.293 | 2657.631 | -372.258 | -258.813 | -465.541 | -3002.161 | 869.542 | 461.054 |
Operating Margin (%) | -4547.35 | -5908.482 | -3537.124 | -11313.793 | -233920 | N/A | N/A | N/A |
Net Profit Margin (%) | -4632.155 | -5995.089 | -3543.144 | -11346.552 | -234760 | N/A | N/A | N/A |
Book Value Per Share | -0.013 | -0.022 | 0.108 | 0.048 | 0.028 | -0.006 | -0.005 | -0.034 |
Earnings Per Share | -0.267 | -0.238 | -0.164 | -0.185 | -0.151 | -0.147 | -0.073 | -0.095 |
Cash Per Share | 0.041 | 0.015 | 0.123 | 0.074 | 0.046 | 0.01 | 0.016 | 0.001 |
Working Capital Per Share | 0.014 | -0.023 | 0.107 | 0.046 | 0.026 | -0.009 | -0.007 | -0.034 |
Operating Profit Per Share | 0.002 | 0.001 | 0.003 | 0.001 | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.267 | -0.238 | -0.164 | -0.185 | -0.151 | -0.147 | -0.073 | -0.095 |
EBITDA Per Share | -0.267 | -0.238 | -0.164 | -0.185 | -0.151 | -0.147 | -0.073 | -0.095 |
Free Cash Flow Per Share | -0.267 | -0.238 | -0.163 | -0.185 | -0.151 | -0.147 | -0.073 | -0.095 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 49,12M | 56,38M | 64,68M | 71,22M | 77,96M | 85,55M | 90,52M | 93,54M |
Fin d'année 31 Décembre 2023 | Mar 2022 | Juin 2022 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 90,28M | 91,27M | 91,27M | 90,52M | 90,52M | 91,27M | 93,27M | 93,54M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 18,71M |
Ratio cours/bénéfice | -2,12 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 285,71 |
Ratio prix/valeur comptable | -5,9 |
Rendement de dividende | - |
Actions en circulation | 93,54M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales